Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin in hospitalized adults with severe acute respiratory syndrome due to COVID-19
RBR-7hzhwdPhase 2Terminated
- Sponsor
- Hospital de Base de São José do Rio Preto
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Ivermectin plus standard treatment with Placebo plus standard treatment (2 arms). Started May 2020; status: terminated.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-7hzhwd.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7hzhwd.